.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Accenture
Boehringer Ingelheim
McKesson
Merck
US Department of Justice
Johnson and Johnson
Healthtrust
Fuji
Farmers Insurance

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077414

« Back to Dashboard

NDA 077414 describes DESMOPRESSIN ACETATE, which is a drug marketed by Bedford, Hospira, Sagent Pharms, Sun Pharm Inds Ltd, Teva Pharms Usa, Sun Pharm Inds, Bausch And Lomb, Actavis Labs Fl Inc, Apotex Inc, Ferring, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, Mylan Pharms Inc, Sun Pharma Global, and Zydus Pharms Usa Inc, and is included in nineteen NDAs. It is available from eighteen suppliers. Additional details are available on the DESMOPRESSIN ACETATE profile page.

The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Summary for 077414

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 077414

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 077414 ANDA Apotex Corp. 60505-0257 60505-0257-1 100 TABLET in 1 BOTTLE (60505-0257-1)
DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 077414 ANDA Apotex Corp. 60505-0257 60505-0257-8 1000 TABLET in 1 BOTTLE (60505-0257-8)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.1MG
Approval Date:Mar 7, 2006TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.2MG
Approval Date:Mar 7, 2006TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Teva
Farmers Insurance
Julphar
Dow
Deloitte
Chubb
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot